iShares U.S. Pharmaceuticals ETF


Добавить в список отслеживания Добавить в список отслеживания
Добавить в портфель Добавить в портфель

Основные параметры

Цена последней сделки 182.5
Код ценной бумаги IHE
Полное наименование iShares U.S. Pharmaceuticals ETF
Объем 360430000000
Изм за день, % 0.02
Комиссия 0.42
Дата основания May 05. 2006
Ссылка ссылка
Тип актива Equity
Индекс Dow Jones U.S. Select Pharmaceuticals Index
Регион North America
Средний P/E 27.41
Дивиденды 1.19
5 летняя доходность 40.84
3 летняя доходность 23.66
Годовая доходность 20.81
Бета 0.93
Валюта usd

Топ эмитентов

Эмитент Доля, % P/BV P/S P/E EV/Ebitda
Johnson & Johnson 23.15 6.59 5.04 28.76 15.69
PFIZER 15.82 2.85 4.44 19.62 15.84
Eli Lilly and Company 5.53 32.92 8 30.18 22.56
Horizon Therapeutics Public Limited Company 5.51 5.2 9.62 52.22 34.88
Elanco Animal Health 4.53 1.9 4.85 51.35
Вторресурсы 4.52 0 0 0.4
Zoetis 4.38 19.58 11.05 45.39 28.78
Bristol-Myers 4.33 3.64 3.23 93.81 9.5
Merck & Co 3.87 6.29 3.83 26.12 11.31
Perrigo 2.05 0.95 1.08 24.33 9.12
ChemoCentryx, Inc. 1.2 11.58 66.52 -104.03
Reata Pharmaceuticals, Inc. 1.18 23.08 538.17 -10.31

Похожие ETF

Описание iShares U.S. Pharmaceuticals ETF

This ETF is one of the options available for investors looking to access the pharmaceutical industry, a sub-sector of health care that has the potential to perform well during periods of consolidation and that may be appealing as a source of capital appreciation over the long run. Given the targeted focus of IHE, this ETF probably isn't that useful as a core holding in a long-term portfolio; it may, however, be appealing to those looking to apply a tactical tilt towards pharma or implement a sector rotation strategy. IHE is somewhat concentrated, with a relatively shallow basket of holdings and significant weightings afforded to the larger companies in the underlying index. Other options for exposure to pharmaceutical firms include PPH (which is extremely concentrated) and XPH, which is linked to an equal-weighted index and therefore may offer better balance. There is also the "Dynamic" PJP, a more expensive option that may be attractive for those who believe the quant-based methodology adds value.